Citation Impact
Citing Papers
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
2018 Science
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
2010
Restoration of Natural Killer Cell Antimetastatic Activity by IL12 and Checkpoint Blockade
2017
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Recognition of Tumors by the Innate Immune System and Natural Killer Cells
2014
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Control of Regulatory T Cells by Co-signal Molecules
2019 StandoutNobel
Determining cell type abundance and expression from bulk tissues with digital cytometry
2019 Standout
Cytomegalovirus reactivation in critically ill immunocompetent hosts: A decade of progress and remaining challenges
2011
Innate IL-17-producing cells: the sentinels of the immune system
2010 Standout
Cytomegalovirus Evasion of Innate Immunity by Subversion of the NKR-P1B:Clr-b Missing-Self Axis
2007
An Acquired and Endogenous Glycocalyx Forms a Bidirectional “Don’t Eat” and “Don’t Eat Me” Barrier to Phagocytosis
2020 StandoutNobel
Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity
2005
Crystal Structure of the Murine Cytomegalovirus MHC-I Homolog m144
2006
Regulation of immune cell function and differentiation by the NKG2D receptor
2011
The Forward Genetic Dissection of Afferent Innate Immunity
2008 StandoutNobel
NK cells for cancer immunotherapy
2020
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
2019
C-type lectins in immunity and homeostasis
2018
Genetic analysis of resistance to viral infection
2007 StandoutNobel
γδ T Cells and the Lymphoid Stress-Surveillance Response
2009
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
NK Cell Exhaustion
2017
Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
2016
Cellular ligands of activating NK receptors
2005
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
The Immune Microenvironment and Cancer Metastasis
2019
Immunosurveillance and immunotherapy of tumors by innate immune cells
2015
Delayed Induction, Not Impaired Recruitment, of Specific CD8+ T Cells Causes the Late Onset of Acute Hepatitis C
2011 StandoutNobel
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
2018
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Mechanism of the Tyrosine Ammonia Lyase Reaction—Tandem Nucleophilic and Electrophilic Enhancement by a Proton Transfer
2012
How host defense is encoded in the mammalian genome
2010 StandoutNobel
A meta-analysis of the impact of short-term sleep deprivation on cognitive variables.
2010 Standout
Self or nonself? That is the question: sensing of cytomegalovirus infection by innate immune receptors
2010
Natural killer cells in viral infection: more than just killers
2006
Functions of natural killer cells
2008 Standout
NK Cell Recognition of Mouse Cytomegalovirus-Infected Cells
2005
Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155
2016
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything
2010
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
2014
Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy
2015
Resisting viral infection: the gene by gene approach
2011 StandoutNobel
MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data
2015 Standout
The DExD/H-box helicase Dicer-2 mediates the induction of antiviral activity in drosophila
2008 StandoutNobel
The immunology of stroke: from mechanisms to translation
2011 Standout
TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer
2021
NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis
2018
Control of Metastasis by NK Cells
2017
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
2014
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Oxidative Stress in Cancer
2020 Standout
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
2009 StandoutNature
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
NK cells and cancer: you can teach innate cells new tricks
2015
Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets
2018
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
2008 StandoutNature
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
2018
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
2018 Standout
Mutations Designed to Destabilize the Receptor-Bound Conformation Increase MICA-NKG2D Association Rate and Affinity
2007 StandoutNobel
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
2016 StandoutNobel
T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling
2014
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Mice with mutations of Dock7 have generalized hypopigmentation and white-spotting but show normal neurological function
2009 StandoutNobel
Control of Human Viral Infections by Natural Killer Cells
2013
Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells
2010 StandoutNobel
TIGIT: A Key Inhibitor of the Cancer Immunity Cycle
2016
Impact of β2 integrin deficiency on mouse natural killer cell development and function
2011 StandoutNobel
Distinct Requirements for Activation of NKT and NK Cells during Viral Infection
2014
Diversity, Mechanisms, and Significance of Macrophage Plasticity
2019 Standout
The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection
2006
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
2020 StandoutNobel
Evidence for Differential Roles for NKG2D Receptor Signaling in Innate Host Defense against Coronavirus-Induced Neurological and Liver Disease
2007 StandoutNobel
TLRs and innate immunity
2008 StandoutNobel
The Herpes Simplex Virus 1 IgG Fc Receptor Blocks Antibody-Mediated Complement Activation and Antibody-Dependent Cellular CytotoxicityIn Vivo
2011
Structural Investigations into the Stereochemistry and Activity of a Phenylalanine-2,3-aminomutase from Taxus chinensis
2014 StandoutNobel
Immunity, inflammation, and cancer: an eternal fight between good and evil
2015
2017
Effect of tumor cells and tumor microenvironment on NK‐cell function
2014
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
TIGIT in cancer immunotherapy
2020
Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response
2009
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
MHC class I Dkexpression in hematopoietic and nonhematopoietic cells confers natural killer cell resistance to murine cytomegalovirus
2010
Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells
2017
ATP-sensitive potassium channel (K ATP )–dependent regulation of cardiotropic viral infections
2011 StandoutNobel
Works of T. Rovis being referenced
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60
2006
Elucidating the Mechanisms of Influenza Virus Recognition by Ncr1
2012
Murine cytomegalovirus regulation of NKG2D ligands
2008
Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1ɛ in addition to MULT-1 and H60
2009
Combined X-ray Diffraction and QM/MM Study of theBurkholderiacepaciaLipase-Catalyzed Secondary Alcohol Esterification
2008
Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity
2020
Differential Susceptibility of RAE-1 Isoforms to Mouse Cytomegalovirus
2009
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
2015 Science
The interaction between CD 300a and phosphatidylserine inhibits tumor cell killing by NK cells
2013
Selective Down-Regulation of the NKG2D Ligand H60 by Mouse Cytomegalovirus m155 Glycoprotein
2005
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145
2005
Inflammatory monocytes and NK cells play a crucial role in DNAM-1–dependent control of cytomegalovirus infection
2016
Mouse TIGIT inhibits NK ‐cell cytotoxicity upon interaction with PVR
2013